Title: Psora-4, a Kv1.3 Blocker, Enhances Differentiation and Maturation in Neural Progenitor Cells.
Journal: CNS neuroscience & therapeutics 20150701
Title: Inhibitors of mitochondrial Kv1.3 channels induce Bax/Bak-independent death of cancer cells.
Journal: EMBO molecular medicine 20120701
Title: Kv1.3 channels as a potential target for immunomodulation of CD4+ CD28null T cells in patients with acute coronary syndrome.
Journal: Clinical immunology (Orlando, Fla.) 20120201
Title: Pharmacological inhibition of Kv1.3 fails to modulate insulin sensitivity in diabetic mice or human insulin-sensitive tissues.
Journal: American journal of physiology. Endocrinology and metabolism 20110801
Title: Identification of phase-I metabolites and chronic toxicity study of the Kv1.3 blocker PAP-1 (5-(4-phenoxybutoxy)psoralen) in the rat.
Journal: Xenobiotica; the fate of foreign compounds in biological systems 20110301
Title: Potent suppression of vascular smooth muscle cell migration and human neointimal hyperplasia by KV1.3 channel blockers.
Journal: Cardiovascular research 20110201
Title: Voltage-gated potassium channel Kv1.3 blocker as a potential treatment for rat anti-glomerular basement membrane glomerulonephritis.
Journal: American journal of physiology. Renal physiology 20101201
Title: N-{3-[(1,1-dioxido-1,2-benzothiazol-3-yl)(phenyl)amino]propyl}benzamide analogs as potent Kv1.3 inhibitors. Part 1.
Journal: Bioorganic & medicinal chemistry letters 20101201
Title: Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Journal: Nature chemical biology 20091001
Title: Transient 5-(4-phenylbutoxy)psoralen (PAP-1) treatment dissociates developing pathologies in autoimmune optic neuritis into two distinct pathology profiles.
Journal: Journal of neuroscience research 20080701
Title: Pharmacokinetics, toxicity, and functional studies of the selective Kv1.3 channel blocker 5-(4-phenoxybutoxy)psoralen in rhesus macaques.
Journal: Experimental biology and medicine (Maywood, N.J.) 20071101
Title: 5-(3-Phenylpropoxy)psoralen and 5-(4-phenylbutoxy)psoralen: mechanistic studies on phototoxicity.
Journal: Die Pharmazie 20050301
Title: Kv1.3-blocking 5-phenylalkoxypsoralens: a new class of immunomodulators.
Journal: Molecular pharmacology 20040601
Title: The voltage-gated Kv1.3 K(+) channel in effector memory T cells as new target for MS.
Journal: The Journal of clinical investigation 20030601
Title: Sustained ER Ca2+ depletion suppresses protein synthesis and induces activation-enhanced cell death in mast cells.
Journal: The Journal of biological chemistry 20020419
